ICUI ICU MEDICAL INC/DE

Did the company actually spend money buying back stock in 3+ of the last 4 quarters?

Bought back stock in 4/4 quarters. Q2 2018: $0M, Q1 2018: $4M, Q3 2017: $0M, Q2 2017: $0M

Is the most recent quarter's buyback spend more than 15% above the trailing average?

Latest quarter $0M vs trailing avg $1M (-98%)

What percentage of free cash flow is going to buybacks? Bull: 30%+. Bear: negative FCF or no buybacks.

Negative FCF ($-21M), buybacks not supported by cash flow

How fast are they shrinking the float? Bull: 2%+ annually. Bear: under 0.5%.

Repurchased 524,655 shares = 2.8% of 24,688,000 outstanding (annualized)

Are officers and directors buying stock with their own money on the open market?

2 open-market purchases by 1 insiders

• Greenberg David C. () bought 602 shares at $126.14 on 2025-08-27
• Greenberg David C. () bought 598 shares at $126.69 on 2025-08-27

Are both company buybacks and insider buying independently active? Bull when the company is buying back stock in 2+ quarters and insiders have made 2+ open-market purchases.

Company buybacks in 4 quarters and 2 insider purchases by 1 insiders (no calendar overlap, but both independently active)

Over the last 90 days, are insiders net buyers or net sellers on the open market?

Insiders bought $0M, sold $3M in the last 90 days (net selling)

Active buyback + insiders net selling 3x+ more than buying. Company cash may be supporting price while insiders exit.

Company buying back stock while insiders sold 31.1x more than bought. 3 C-suite officers among sellers

• Sousa Ben (Chief Information Officer) sold 2,250 shares on 2026-08-12
• Voigtlander Christian B. (Chief Operating Officer) sold 8,929 shares on 2026-08-11
• Woolson Daniel (President) sold 2,123 shares on 2026-05-22